Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 163, Suchdauer: 1.12s

12 3 4 5 6 7 weiter »

1
Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial

von Kelly, Eimear ; Greenland, Melanie ; de Whalley, Philip C.S. ; et al.

In Journal of Infection September 2023 87(3):230-241
- View full text via DOI
Merkliste

2
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study – A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines

von Shaw, Robert H. ; Greenland, Melanie ; Stuart, Arabella S.V. ; et al.

In Journal of Infection June 2023 86(6):574-583
- View full text via DOI
Merkliste

3
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial

von Munro, Alasdair P.S. ; Bartholomew, Jazz ; Presland, Laura ; et al.

In The Lancet Respiratory Medicine November 2022 10(11):1049-1060
- View full text via DOI
Merkliste

4
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: Final results of a phase 2, single-blind, randomised controlled trial (COV006)

von Aley, Robert ; Anslow, Rachel ; Cathie, Katrina ; et al.

In Vaccine 30 August 2025 62
- View full text via DOI
Merkliste

5
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents

von Ratcliffe, Helen ; Tiley, Karen S. ; Longet, Stephanie ; et al.

In iScience 15 December 2023 26(12)
- View full text via DOI
Merkliste

6
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

von Munro, Alasdair P S ; Feng, Shuo ; Janani, Leila ; et al.

In The Lancet Infectious Diseases August 2022 22(8):1131-1141
- View full text via DOI
Merkliste

7
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

von Emary, Katherine R W ; Golubchik, Tanya ; Aley, Parvinder K ; et al.

In The Lancet 10-16 April 2021 397(10282):1351-1362
- View full text via DOI
Merkliste

8
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

von Aban, Marites ; Abeyskera, Kushala W.M. ; Aboagye, Jeremy ; et al.

In The Lancet 6-12 March 2021 397(10277):881-891
- View full text via DOI
Merkliste

9
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

von Aban, Marites ; Abayomi, Fatola ; Abeyskera, Kushala ; et al.

In The Lancet 9-15 January 2021 397(10269):99-111
- View full text via DOI
Merkliste

10
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

von Watson, Marion E.E. ; Song, Rinn ; Cicconi, Paola ; et al.

In The Lancet HIV August 2021 8(8):e474-e485
- View full text via DOI
Merkliste

11
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

von Aboagye, Jeremy ; Adams, Kelly ; Ali, Aabidah ; et al.

In The Lancet 19 December 2020-1 January 2021 396(10267):1979-1993
- View full text via DOI
Merkliste

12
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

von Aboagye, Jeremy ; Adams, Kelly ; Ali, Aabidah ; et al.

In The Lancet 15-21 August 2020 396(10249):467-478
- View full text via DOI
Merkliste

13
ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses

von Ebrahimi, Narges ; de Whalley, Philip ; Kanji, Nasir ; et al.

In Vaccine 13 August 2026 88
- View full text via DOI
Merkliste

14
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

von Feng, Shuo ; Phillips, Daniel J. ; White, Thomas ; et al.

Nature Medicine. 27(11):2032-2040
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

15
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

von Ewer, Katie J. ; Barrett, Jordan R. ; Belij-Rammerstorfer, Sandra ; et al.

Nature Medicine. 27(2):270-278
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

16
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

von Barrett, Jordan R. ; Belij-Rammerstorfer, Sandra ; Dold, Christina ; et al.

Nature Medicine. 27(2):279-288
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

17
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial

von Shaw, Robert H ; Liu, Xinxue ; Stuart, Arabella S V ; et al.

Schlagworte: Pulmonary and Respiratory Medicine
- View full text via BASE
Merkliste

18
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV

von Ane Ogbe ; Matthew Pace ; Mustapha Bittaye ; et al.

JCI Insight, Vol 7, Iss 7 (2022)

Schlagworte: AIDS/HIV; COVID-19; Medicine
- View full text via DOI
Merkliste

19
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

von Stuart, Arabella S V ; Shaw, Robert H ; Liu, Xinxue ; et al.

The Lancet ; volume 399, issue 10319, page 36-49 ; ISSN 0140-6736
- View full text via BASE
Merkliste

20
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

von Stuart, Arabella S V ; Shaw, Robert H ; Liu, Xinxue ; et al.

Schlagworte: General Medicine
- View full text via BASE
Merkliste

21
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

von Liu, Xinxue ; Shaw, Robert H ; Stuart, Arabella S V ; et al.
- View full text via BASE
Merkliste

22
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

von Ewer, Katie J. ; Barrett, Jordan R. ; Belij-Rammerstorfer, Sandra ; et al.

Nature Medicine. 27(6):1116-1116
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

23
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

von Barrett, Jordan R. ; Belij-Rammerstorfer, Sandra ; Dold, Christina ; et al.

Nature Medicine. 27(6):1113-1113
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

24
Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infants

von Goldblatt, David ; Andrews, Nick J. ; Sheppard, Carmen L. ; et al.

In Vaccine 5 May 2023 41(19):3019-3023
- View full text via DOI
Merkliste

25
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

von Soiza, Roy L. ; Brittain-Long, Robin ; Scicluna, Chiara ; et al.

In The Lancet Respiratory Medicine February 2022 10(2):167-179
- View full text via DOI
Merkliste

12 3 4 5 6 7 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag